Sino Biopharmaceutical reported CNY10.5B in Gross Profit on Sales for its fiscal semester ending in December of 2024.





Gross Profit On Sales Change Date
Akebia Therapeutics USD 47.28M 1.7M Dec/2025
Alaunos Therapeutics USD -1.13M 1.11M Sep/2024
Avita Medical AUD 14.31M 639K Dec/2025
Cspc Pharmaceutical CNY 4.01B 329.18M Dec/2025
Dianthus Therapeutics USD 463K 179K Mar/2026
Ionis Pharmaceuticals USD 265M 22M Jun/2026
IQVIA Holdings USD 1.44B 368M Jun/2026
Jiangsu Hengrui CNY 7.27B 918.27M Dec/2025
Moderna USD -566M 792M Mar/2026
Organon & Co USD 783M 71M Mar/2026
Revvity USD 416.87M 29.21M Jun/2026
Sino Biopharmaceutical CNY 10.5B 2.53B Dec/2024
Tectonic Therapeutic USD 0 0 Mar/2025
Viatris USD 1.57B 193.9M Jun/2026
Xeris Pharmaceuticals USD 72.55M 404K Mar/2026